{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:36:24Z","timestamp":1790678184347,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"JSPS Postdoctoral Fellowship for Research Abroad"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.antiviral.2017.11.004","type":"journal-article","created":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T06:31:15Z","timestamp":1510122675000},"page":"34-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"special_numbering":"C","title":["Merimepodib, an IMPDH inhibitor, suppresses replication of Zika virus and other emerging viral pathogens"],"prefix":"10.1016","volume":"149","author":[{"given":"Xiao","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanon","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalya","family":"Bukreyeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Koma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Manning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Kalkeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann D.","family":"Kwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slobodan","family":"Paessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2017.11.004_bib1","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/cid\/ciw571","article-title":"Clinical and virological characteristics of Ebola virus disease patients treated with favipiravir (T-705) - Sierra Leone, 2014","volume":"63","author":"Bai","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.11.004_bib2","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1086\/657315","article-title":"Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever","volume":"51","author":"Bausch","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.11.004_bib3","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1126\/science.aaa3778","article-title":"Combating emerging viral threats","volume":"348","author":"Bekerman","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2017.11.004_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2007.12.007","article-title":"Highly pathogenic RNA viral infections: challenges for antiviral research","volume":"78","author":"Bray","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.11.004_bib5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.antiviral.2016.11.023","article-title":"The FDA-approved drug sofosbuvir inhibits Zika virus infection","volume":"137","author":"Bullard-Feibelman","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.11.004_bib6","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jinf.2016.02.011","article-title":"Zika fever and congenital Zika syndrome: an unexpected emerging arboviral disease","volume":"72","author":"Chan","year":"2016","journal-title":"J. Infect."},{"key":"10.1016\/j.antiviral.2017.11.004_bib7","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1126\/science.353.6299.529","article-title":"Zika vaccine has a good shot","volume":"353","author":"Cohen","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2017.11.004_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4103\/0972-9062.117470","article-title":"Emerging and re-emerging arboviral diseases in Southeast Asia","volume":"50","author":"Dash","year":"2013","journal-title":"J. Vector Borne Dis."},{"key":"10.1016\/j.antiviral.2017.11.004_bib9","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1128\/JVI.02102-10","article-title":"Rescue from cloned cDNAs and in vivo characterization of recombinant pathogenic romero and live-attenuated Candid #1 strains of Junin virus, the causative agent of argentine hemorrhagic fever disease","volume":"85","author":"Emonet","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2017.11.004_bib10","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.antiviral.2007.10.010","article-title":"Treatment of Argentine hemorrhagic fever","volume":"78","author":"Enria","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.11.004_bib11","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.antiviral.2013.09.015","article-title":"Favipiravir (T-705), a novel viral RNA polymerase inhibitor","volume":"100","author":"Furuta","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.11.004_bib12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jviromet.2016.09.015","article-title":"A sensitive virus yield assay for evaluation of Antivirals against Zika Virus","volume":"238","author":"Goebel","year":"2016","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.antiviral.2017.11.004_bib13","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMp1603734","article-title":"The zika challenge","volume":"374","author":"Haug","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2017.11.004_bib14","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1021\/cr900021w","article-title":"IMP dehydrogenase: structure, mechanism, and inhibition","volume":"109","author":"Hedstrom","year":"2009","journal-title":"Chem. Rev."},{"key":"10.1016\/j.antiviral.2017.11.004_bib15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.antiviral.2016.11.003","article-title":"Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model","volume":"137","author":"Julander","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.11.004_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2010.10.009","article-title":"Cellular IMPDH enzyme activity is a potential target for the inhibition of Chikungunya virus replication and virus induced apoptosis in cultured mammalian cells","volume":"89","author":"Khan","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.11.004_bib17","doi-asserted-by":"crossref","first-page":"4864","DOI":"10.1128\/JVI.00252-16","article-title":"Zika virus: new clinical syndromes and its emergence in the western hemisphere","volume":"90","author":"Lazear","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2017.11.004_bib18","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1126\/science.aaf8160","article-title":"Assessing the global threat from Zika virus","volume":"353","author":"Lessler","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2017.11.004_bib19","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2016.21.26.30269","article-title":"Detection of Zika virus RNA in whole blood of imported Zika virus disease cases up to 2 months after symptom onset, Israel, December 2015 to April 2016","volume":"21","author":"Lustig","year":"2016","journal-title":"Eurosurveill."},{"key":"10.1016\/j.antiviral.2017.11.004_bib20","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jhep.2007.03.028","article-title":"Phase 2 study of the combination of merimepodib with peginterferon-alpha2b, and ribavirin in nonresponders to previous therapy for chronic hepatitis C","volume":"47","author":"Marcellin","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2017.11.004_bib21","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1128\/AAC.44.4.859-866.2000","article-title":"Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX- 497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon","volume":"44","author":"Markland","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2017.11.004_bib22","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.cell.2016.05.008","article-title":"Zika virus infection during pregnancy in mice causes placental damage and fetal demise","volume":"165","author":"Miner","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2017.11.004_bib23","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1016\/j.celrep.2016.08.079","article-title":"Zika virus infection in mice causes panuveitis with shedding of virus in tears","volume":"16","author":"Miner","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.antiviral.2017.11.004_bib24","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.cmi.2016.12.027","article-title":"Sexually acquired Zika virus: a systematic review","volume":"23","author":"Moreira","year":"2017","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.antiviral.2017.11.004_bib25","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ajpath.2010.11.018","article-title":"A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence","volume":"178","author":"Morrison","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.antiviral.2017.11.004_bib26","doi-asserted-by":"crossref","first-page":"9683","DOI":"10.1128\/JVI.01347-16","article-title":"Inhibition of polyamine biosynthesis is a broad-spectrum strategy against RNA viruses","volume":"90","author":"Mounce","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2017.11.004_bib27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.antiviral.2011.05.006","article-title":"Depletion of GTP pool is not the predominant mechanism by which ribavirin exerts its antiviral effect on Lassa virus","volume":"91","author":"\u00d6lschl\u00e4ger","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.11.004_bib28","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.cell.2016.09.020","article-title":"Zika virus: immunity and vaccine development","volume":"167","author":"Pierson","year":"2016","journal-title":"Cell."},{"key":"10.1016\/j.antiviral.2017.11.004_bib29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.chom.2016.05.015","article-title":"Zika virus infects human placental macrophages","volume":"20","author":"Quicke","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2017.11.004_bib30","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2014.19.41.20929","article-title":"Concurrent outbreaks of dengue, chikungunya and zika virus infections - an unprecedented epidemic wave of mosquito-borne viruses in the Pacific 2012-2014","volume":"19","author":"Roth","year":"2014","journal-title":"Eurosurveill."},{"key":"10.1016\/j.antiviral.2017.11.004_bib31","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/hep.23204","article-title":"Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders","volume":"50","author":"Rustgi","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2017.11.004_bib32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0162-3109(00)00193-4","article-title":"The structure of inosine 5\u2019-monophosphate dehydrogenase and the design of novel inhibitors","volume":"47","author":"Sintchak","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.antiviral.2017.11.004_bib33","article-title":"Experimental treatment with favipiravir for Ebola virus disease (the JIKI trial): a historically controlled, single-arm proof-of-concept trial in Guinea","volume":"13","author":"Sissoko","year":"2016","journal-title":"PLoS Med."},{"key":"10.1016\/j.antiviral.2017.11.004_bib34","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.chom.2016.07.002","article-title":"Zika virus targets different primary human placental cells, suggesting two routes for vertical transmission","volume":"20","author":"Tabata","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2017.11.004_bib35","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.mjafi.2016.02.017","article-title":"Dengue, chikungunya\u2026 and the missing entity - zika fever: a new emerging threat","volume":"72","author":"Tilak","year":"2016","journal-title":"Med. J. Armed Forces India"},{"key":"10.1016\/j.antiviral.2017.11.004_bib36","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.3390\/v4091802","article-title":"Animal models, prophylaxis, and therapeutics for arenavirus infections","volume":"9","author":"Vela","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2017.11.004_bib37","first-page":"207","article-title":"Anatomical, animal, and cellular evidence for Zika-induced pathogenesis of fetal microcephaly","volume":"39","author":"Wang","year":"2016","journal-title":"Brain Dev."},{"key":"10.1016\/j.antiviral.2017.11.004_bib38","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.antiviral.2009.10.008","article-title":"Present and future arboviral threats","volume":"85","author":"Weaver","year":"2010","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.11.004_bib39","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.antiviral.2015.12.006","article-title":"Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses","volume":"126","author":"Westover","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.11.004_bib40","doi-asserted-by":"crossref","first-page":"10908","DOI":"10.1128\/JVI.01433-13","article-title":"Mice lacking functional STAT1 are highly susceptible to lethal infection with Lassa virus","volume":"87","author":"Yun","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2017.11.004_bib41","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.micinf.2016.03.003","article-title":"Zika virus - an overview","volume":"18","author":"Zanluca","year":"2016","journal-title":"Microbes Infect."},{"key":"10.1016\/j.antiviral.2017.11.004_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004695","article-title":"The viral polymerase inhibitor 7-deaza-2\u2019-C-methyladenosine is a potent inhibitor of in vitro zika virus replication and delays disease progression in a robust mouse infection model","volume":"10","author":"Zmurko","year":"2016","journal-title":"PLoS Negl. Trop. Dis."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217302371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217302371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T12:01:45Z","timestamp":1719576105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354217302371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":42,"alternative-id":["S0166354217302371"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.11.004","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Merimepodib, an IMPDH inhibitor, suppresses replication of Zika virus and other emerging viral pathogens","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}